Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0133-2024Class II

THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to...

B Braun Medical Inc / initiated 2023-09-26 / Open, Classified / root cause: manufacturing process

B. Braun Medical, Inc. began a recall of THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to deliver Yttrium-90 glass microspheres for internal... on . FDA classified it as Class II and gives the reason as "Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0133-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
B Braun Medical Inc
Product
THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to deliver Yttrium-90 glass microspheres for internal radiation therapy.
Product code
ONB Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System
Reason for recall
Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On September 26, 2023, the firm notified customers via Urgent Product Recall Notification letters. Customers were informed of the potential for leakage at the male Luer lock site. Customers were instructed to report total amount of impacted product on hand to the firm, after which B Braun Customer Support will contact the customer with instructions on how to return the product for credit or replacement depending on the customer's need. Questions about this recall may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464.
Quantity in commerce
760 units
Distribution
Worldwide distribution - US Nationwide and the countries of Canada and Singapore.
Product codes and lots
UDI-DI: 5060116920635 Lot 0061790166

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0133-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0128-2024Class IIOngoingVoluntary: Firm initiated
Z-0129-2024Class IIOngoingVoluntary: Firm initiated
Z-0130-2024Class IIOngoingVoluntary: Firm initiated
Z-0131-2024Class IIOngoingVoluntary: Firm initiated
Z-0132-2024Class IIOngoingVoluntary: Firm initiated
Z-0133-2024Class IIOngoingVoluntary: Firm initiated
Z-0134-2024Class IIOngoingVoluntary: Firm initiated
Z-0135-2024Class IIOngoingVoluntary: Firm initiated
Z-0136-2024Class IIOngoingVoluntary: Firm initiated